Ernodasa

Ernodasa contains Streptodornase and Streptokinase, enzymes used for enzymatic debridement. This medication helps break down dead tissue and debris, promoting wound healing. Ideal for managing necrotic wounds and improving tissue regeneration.

Ernodasa is primarily used for enzymatic debridement, which involves breaking down dead tissue and debris in wounds. This process aids in wound healing and tissue regeneration. It is often applied to necrotic wounds to promote better healing outcomes. The enzymes in Ernodasa help clear away dead tissue, allowing healthy tissue to grow and heal more effectively.

When applied topically, Ernodasa may cause mild irritation or redness at the application site. Some users might experience a slight burning sensation or discomfort. These effects are generally temporary and should subside as the body adjusts to the treatment. If irritation persists, it is advisable to consult a healthcare professional.

Ernodasa should be used with caution in individuals with known allergies to Streptodornase or Streptokinase. It is important to follow the prescribed application instructions to avoid excessive irritation. Keep the medication out of reach of children and store it as directed to maintain its efficacy.

Ernodasa may interact with other topical medications, potentially altering their effectiveness. It is advisable to avoid using other topical treatments on the same area without consulting a healthcare professional. Additionally, individuals should be cautious when combining Ernodasa with other enzymatic treatments to prevent adverse reactions.